Reply to P.S.N. van Rossum et al and J. Shapiro et al

Affiliations

Comment

Christophe Mariette et al. J Clin Oncol. 2015.

. 2015 Jan 20;33(3):289.

doi: 10.1200/JCO.2014.59.3293. Epub 2014 Dec 1.

¹ University Hospital of Lille, Lille, France Christophe.mariette@chru-lille.fr.
² University Hospital of Lille, Lille, France.

No abstract available

Comment on

Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901.
Mariette C, Dahan L, Mornex F, Maillard E, Thomas PA, Meunier B, Boige V, Pezet D, Robb WB, Le Brun-Ly V, Bosset JF, Mabrut JY, Triboulet JP, Bedenne L, Seitz JF. Mariette C, et al. J Clin Oncol. 2014 Aug 10;32(23):2416-22. doi: 10.1200/JCO.2013.53.6532. Epub 2014 Jun 30. J Clin Oncol. 2014. PMID: 24982463 Clinical Trial.
Effectiveness of neoadjuvant chemoradiotherapy for early-stage esophageal cancer.
Shapiro J, van Lanschot JJ, Hulshof MC, van der Gaast A. Shapiro J, et al. J Clin Oncol. 2015 Jan 20;33(3):288-9. doi: 10.1200/JCO.2014.59.2428. Epub 2014 Dec 1. J Clin Oncol. 2015. PMID: 25452442 No abstract available.
Neoadjuvant chemoradiotherapy for stage I and II esophageal cancer.
van Rossum PSN, van Hillegersberg R, Reerink O, Ruurda JP. van Rossum PSN, et al. J Clin Oncol. 2015 Jan 20;33(3):287-8. doi: 10.1200/JCO.2014.58.1272. Epub 2014 Dec 1. J Clin Oncol. 2015. PMID: 25452449 No abstract available.